|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 78, 244-253, Copyright © 1979 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
WH Fennell, KG Chua, L Cohen, J Morgan, HB Karunaratne, L Resnekov, J Al-Sadir, CY Lin, JJ Lamberti and CE Anagnostopoulos
One hundred consecutive patients undergoing aorta-coronary bypass grafting
(ACBG) alone, without ventricular venting, were prospectively studied to
determine the incidence and consequence of perioperative myocardial
infarction (PMI) and the clinical variables that were predictive of PMI.
Incidence was determined by serial electrocardiography (ECG) 100 patients;
serum CK, GOT, and LDH (100 patients). CK isoenzymes (qualitative 100
patients, quantitated 50 patients); vectorcardiography (VCG) (78 patients);
and 99mtechnetium pyrophosphate scintigraphy (TcPyp) (52 patients). The
incidence of PMI by ECG was 9%; an additional 8% of cases was diagnosed by
enzymes alone. The incidence of diagnostic change by VCG was 19% and by
scintigraphy, 25%. Using at least one changed variable of the remaining
three as the reference standard, the relative sensitivity and relative
specificity of given variables in the diagnosis of PMI were as follows: ECG
67% and 100%, respectively; VCG 85% and 94%; scintigraphy 92% and 97%; and
serum enzymes 86% and 96%. By univariate analysis, unstable angina was the
only significant predictor of PMI. The operative mortality rate was 2% and
the mortality rate at 12 months was 5%. There was a significantly greater
mortality rate in patients with PMI diagnosed by ECG (p less than 0.01), in
patients with unstable angina pectoris before operation (p less than 0.05),
and in women (p less than 0.05).
ARTICLES
Detection, prediction, and significance of perioperative myocardial infarction following aorta-coronary bypass
This article has been cited by other articles:
![]() |
P. Menasche, W. R. E. Jamieson, W. Flameng, M. K. Davies, and on behalf of the Multinational Acadesine Study Gro ACADESINE: A NEW DRUG THAT MAY IMPROVE MYOCARDIAL PROTECTION IN CORONARY ARTERY BYPASS GRAFTINGResults of the first international multicenter study J. Thorac. Cardiovasc. Surg., October 1, 1995; 110(4): 1096 - 1106. [Abstract] [Full Text] |
||||
![]() |
A. J. Roberts, S. M. Spies, P. R. Lichtenthal, J. M. Moran, J. H. Sanders, and L. L. Michaelis Changes in Left Ventricular Performance Related to Perioperative Myocardial Infarction in Coronary Artery Bypass Graft Surgery Ann. Thorac. Surg., May 1, 1983; 35(5): S0003497510604250 - S0003497510604250. [Abstract] [PDF] |
||||
![]() |
A. J. Roberts Perioperative Myocardial Infarction and Changes in Left Ventricular Performance Related to Coronary Artery Bypass Graft Surgery Ann. Thorac. Surg., February 1, 1983; 35(2): 208 - 225. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |